Pharmacy Podcast Network

• Targeted Acute Pain Relief: The Role of Topical NSAID Patches in Sports Medicine | Yaral Pharma

  In this episode, YARAL Pharma CEO, Stephen Beckman joins clinical sports pharmacist Jessica Beal, PharmD. to discuss an important topic for athletes and active individuals – the role topical NSAID patches can play in acute pain management. Listeners can visit www.YARALPharma.com to learn more about the company and its products or connect on LinkedIn.    Diclofenac Epolamine Topical System 1.3%    Diclofenac Epolamine Topical System 1.3% is a nonsteroidal anti-inflammatory drug (NSAID) used for treating acute pain from minor strains, sprains, and bruises in adults and children aged 6 and older.     Serious side effects may include increased risk of cardiovascular and gastrointestinal (GI) events. NSAIDs can raise the risk of heart attack, stroke, gastrointestinal bleeding, ulceration, and perforation of the stomach and intestines, which can be fatal. The risk for serious cardiovascular events may occur early in treatment and may increase with duration of use. Elderly patients and those with a history of peptic ulcer disease or GI bleeding are at higher risk for serious GI events.    Do not use in patients who are allergic to diclofenac or any of its ingredients, or have a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Do not use in the setting of coronary artery bypass graft surgery. Avoid use on broken skin. Discontinue immediately if signs of hypersensitivity occur.      Patients should be informed about the warning signs and symptoms of liver problems. Discontinue use if abnormal liver tests persist or worsen or if signs of liver disease develop. Avoid using Diclofenac Epolamine Topical System 1.3% in patients with severe heart failure unless the benefits are expected to outweigh the risks.    The most common side effects include itching, nausea, and headache. Patients should stop use and consult their doctor at the first sign of skin rash or other signs of sensitivity.    Patients should ask their doctor if Diclofenac Epolamine Topical System 1.3% is right for them. For more information and Full Prescribing Information including Boxed Warning and Important Safety Information, visit www.yaralpharma.com   Dr. Beal is not affiliated with YARAL Pharma. All views and opinions regarding pain management are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. 

  --------  

  36:57

  --------

  36:57
• LIVE at RBC 2025 Episode One | Cardinal Health™ Counter Talk™ Podcast

  Tune in to a multi-episode recap of the Retail Business Conference with returning special guest host Adam Robinson, Owner of Save-Rite Drugs in Lexington, Kentucky. Receive the highlights from Cardinal Health customers, employees, services and more at RBC 2025. This episode's topic is navigating Part B Biling for CGM Devices. This discussion will dive into the nuances that make Medicare billing a challenge for pharmacies and ways Cardinal may be able to help.

  --------  

  35:14

  --------

  35:14
• Who is KeySource? A Trusted Partner in a Challenging Industry | Supply, Trust, and the Business of Pharmacy

  Welcome to the first episode of Supply, Trust, and the Business of Pharmacy hosted by Andrew Crawford.

  --------  

  30:22

  --------

  30:22
• The Silent Threat: Diversion of Non-Controlled Substances in Healthcare | TWIRx

  This Week in Pharmacy – July 25, 2025 Episode Summary: This week, we spotlight a growing but often overlooked threat to patient safety and healthcare integrity: the diversion of non-controlled substances. While most discussions around drug diversion focus on controlled substances, a troubling pattern has emerged involving medications not classified as controlled—yet still susceptible to misuse, theft, and exploitation. Our guest is Alan McGill, a Senior Supervisory Special Agent with over 30 years of investigative experience, including 23 years in law enforcement. Agent McGill is a nationally recognized expert on drug diversion, having trained thousands across healthcare and law enforcement. In this episode, he sheds light on how non-controlled substances are being diverted within healthcare settings, why it’s happening more frequently, and what pharmacies and healthcare systems must do to detect and prevent it. We explore: Common myths about non-controlled medications and diversion risk Real-world cases and investigative red flags Compliance blind spots in retail and institutional pharmacy settings Actionable recommendations for pharmacists, techs, and healthcare leadership The role of education, oversight, and reporting in stopping this silent epidemic Plus, Agent McGill discusses his work with NASCSA and offers insight into how national policy and local practices can align to protect both patients and professionals. Don’t miss this essential conversation for pharmacy leaders, compliance officers, and healthcare professionals committed to medication safety. 🎧 Listen now and stay informed.  📢 Brought to you by IPC and iCare+, supporting pharmacy excellence and compliance integrity. The Silent Threat: Diversion of Non-Controlled Substances in Healthcare | TWIRx  

  --------  

  45:48

  --------

  45:48
• LTC Pharmacy at Home: Redefining Independent Pharmacy Growth | RxSafe Series Part 2

  Building Your LTC Pharmacy at Home Business (Part 2)  🎙️ Presented by the Pharmacy Podcast Network | Sponsored by RxSafe Eyecon In Part 2 of our special three-part series “Building Your LTC Pharmacy at Home Business,” we go beyond the vision and focus on the systems that make long-term care at home work — financially, operationally, and clinically. This episode features insights from top leaders in pharmacy program development and technology: Jennifer Whalen, MBA – Medsense, guiding us through payer alignment, compliance, and program structure. Susan Rhoads & Cole Page – GeriMed, on how they’ve helped hundreds of community pharmacies shift into reimbursable LTC care models. Brian Glaves – RxSafe Eyecon, breaking down how automation and verification tools drive accurate dispensing, documentation, and revenue capture. Key Topics: Billing & Reimbursement: Learn how to transition from traditional retail models to get paid for LTC-at-home services. Technology Integration: Eyecon, RxSafe, and software platforms help streamline packaging, compliance, and inventory tracking. Home-Based Patient Care: Pharmacists are becoming central to aging-in-place strategies—this is how to build trust and care continuity. Implementation Strategy: Practical guidance on referral networks, payer contracting, and working with care teams. 📲 Listen now to learn how to operationalize your LTC-at-home pharmacy and turn it into a sustainable, profitable service model. 🔗 Learn more at RxSafe.com 🎧 Available wherever you get your podcasts – Pharmacy Podcast Network 💡 Brought to you by RxSafe and Eyecon – Smart tech for serious care delivery.

  --------  

  48:36

  --------

  48:36

Więcej Edukacja podcastów

Trendy w podcaście Edukacja

O Pharmacy Podcast Network

Pharmacy Podcast Network: Podcasty w grupie